Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma

Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma

<sup>123</sup>I-meta-iodobenzylguanidine (<sup>123</sup>I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. <sup>131</sup>I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy...

Full description

Bibliographic Details
Main Authors: Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Diagnostics
Subjects:
diagnostic <sup>123</sup>I-mIBG scintigraphy
post-therapeutic <sup>131</sup>I-mIBG scintigraphy
high-risk neuroblastoma
consolidation therapy
Online Access:https://www.mdpi.com/2075-4418/10/9/663

Internet

https://www.mdpi.com/2075-4418/10/9/663

Similar Items